These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32802045)

  • 1. Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy.
    Topkan E; Mertsoylu H; Kucuk A; Besen AA; Sezer A; Sezen D; Bolukbasi Y; Selek U; Pehlivan B
    Gastroenterol Res Pract; 2020; 2020():5701949. PubMed ID: 32802045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy.
    Topkan E; Selek U; Pehlivan B; Kucuk A; Haksoyler V; Kilic Durankus N; Sezen D; Bolukbasi Y
    J Inflamm Res; 2021; 14():4433-4444. PubMed ID: 34511977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy.
    Topkan E; Mertsoylu H; Ozdemir Y; Sezer A; Kucuk A; Besen AA; Ozyilkan O; Selek U
    Cancer Manag Res; 2019; 11():8807-8815. PubMed ID: 31632140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
    Topkan E; Kucuk A; Ozdemir Y; Mertsoylu H; Besen AA; Sezen D; Bolukbasi Y; Pehlivan B; Selek U
    J Immunol Res; 2020; 2020():8628540. PubMed ID: 33274245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy.
    Kucuk A; Ozkan EE; Eskici Oztep S; Mertsoylu H; Pehlivan B; Selek U; Topkan E
    J Oncol; 2020; 2020():8832145. PubMed ID: 33381177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining the systemic inflammation response index and prognostic nutritional index to predict the prognosis of locally advanced elderly esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.
    Yan K; Wei W; Shen W; Du X; Zhu S; Zhao H; Wang X; Yang J; Zhang X; Deng W
    J Gastrointest Oncol; 2022 Feb; 13(1):13-25. PubMed ID: 35284132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.
    Hu M; Xu Q; Yang S; Han S; Zhu Y; Lin Q; Sun X; Liu H; Xu Y
    Ann Transl Med; 2020 Oct; 8(20):1310. PubMed ID: 33209890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
    Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
    Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Ding Y; Liu Z; Li J; Niu W; Li C; Yu B
    BMC Surg; 2024 Mar; 24(1):89. PubMed ID: 38481180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas.
    Topkan E; Selek U; Kucuk A; Pehlivan B
    J Inflamm Res; 2022; 15():5413-5423. PubMed ID: 36158517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients.
    Kucuk A; Topkan E; Selek U; Haksoyler V; Mertsoylu H; Besen AA; Pehlivan B
    Ther Clin Risk Manag; 2022; 18():421-428. PubMed ID: 35444422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma.
    Li S; Xu H; Wang W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Wu C; Liu L
    Cancer Manag Res; 2019; 11():3327-3337. PubMed ID: 31114368
    [No Abstract]   [Full Text] [Related]  

  • 13. A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer.
    Pacheco-Barcia V; Mondéjar Solís R; France T; Asselah J; Donnay O; Zogopoulos G; Bouganim N; Guo K; Rogado J; Martin E; Alcindor T; Colomer R
    Pancreatology; 2020 Mar; 20(2):254-264. PubMed ID: 31866391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy.
    Haksoyler V; Topkan E
    Ther Clin Risk Manag; 2021; 17():691-700. PubMed ID: 34262282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Utility of Prechemoradiotherapy Albumin-to-Alkaline Phosphatase Ratio in Unresectable Locally Advanced Pancreatic Carcinoma Patients.
    Haksoyler V; Topkan E
    Gastroenterol Res Pract; 2021; 2021():6647145. PubMed ID: 33927759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    Cancer Manag Res; 2020; 12():1543-1567. PubMed ID: 32184659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis.
    Topkan E; Selek U; Kucuk A; Haksoyler V; Ozdemir Y; Sezen D; Mertsoylu H; Besen AA; Bolukbasi Y; Ozyilkan O; Pehlivan B
    J Oncol; 2021; 2021():6688138. PubMed ID: 33552158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy.
    Topkan E; Ozdemir Y; Kucuk A; Guler OC; Sezer A; Besen AA; Mertsoylu H; Senyurek S; Kilic Durankus N; Bolukbasi Y; Selek U; Pehlivan B
    J Oncol; 2020; 2020():3127275. PubMed ID: 33082783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postchemoradiotherapy systemic inflammation response index predicts treatment response and overall survival for patients with locally advanced nasopharyngeal cancer.
    Lu YF; Wu CY; Lo WC; Chiu YL; Shueng PW; Hsieh CH; Hsu CX; Kuo DY; Hou PY; Liao LJ
    J Formos Med Assoc; 2023 Nov; 122(11):1141-1149. PubMed ID: 37202235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE.
    Wang TC; An TZ; Li JX; Pang PF
    Risk Manag Healthc Policy; 2021; 14():2589-2600. PubMed ID: 34188570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.